These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 20137485)

  • 1. The importance of using peritoneal equlibration test for the peritoneal transport type characterization in continuous ambulatory peritoneal dialysis patients.
    Uncanin S; Rasić S; Rebić D; Dzemidzić J; Muslimović A; Begović B; Herenda V
    Bosn J Basic Med Sci; 2010 Apr; 10 Suppl 1(Suppl 1):S40-3. PubMed ID: 20433430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Transport Characteristics at the Beginning and in Long Term Peritoneal Dialysis: a Single Center Experience.
    Uncanin S; Serdarevic N; Klapuh N; Haskovic E
    Mater Sociomed; 2020 Jun; 32(2):99-104. PubMed ID: 32843855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of DUSP6 in peripheral blood mononuclear cells in predicting adverse cardiovascular events after peritoneal dialysis in diabetic nephropathy.
    Guo B; Liu J; Han X; Li Y; Tian X; Jin X; Wei Z; Liu S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):359-366. PubMed ID: 38970509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function.
    Hamdan Z; Abdel-Hafez Y; Enaya A; Sarsour A; Kharraz L; Nazzal Z
    BMC Nephrol; 2024 Jan; 25(1):37. PubMed ID: 38279109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NEAT1 levels on cardiovascular events and prognosis in diabetic nephropathy patients undergoing peritoneal dialysis.
    Liu M; Yan Z; Zhang Y; Zhang S
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):178-183. PubMed ID: 38814218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Peritoneal Glucose Absorption, Lipid Metabolism, and Cardiovascular Disease Risk in Nondiabetic Patients on Peritoneal Dialysis.
    Wang J; Zhao J; Li L; Lin X; Guo X; Peng F; Zuo X; Liu X; Ying C
    J Ren Nutr; 2024 Jun; ():. PubMed ID: 38851308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and mortality of new-onset glucose disorders in peritoneal dialysis patients in China: a meta-analysis.
    Shi Y; Cai J; Shi C; Liu C; Li Z
    BMC Nephrol; 2020 Apr; 21(1):152. PubMed ID: 32349684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of standardized equilibration tests in CAPD patients.
    Twardowski ZJ
    Blood Purif; 1989; 7(2-3):95-108. PubMed ID: 2663040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of peritoneal function in CAPD patients].
    Yamashita AC
    Nihon Rinsho; 2004 May; 62 Suppl 5():281-5. PubMed ID: 15197930
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients on continuous ambulatory peritoneal dialysis.
    Yu XF; Zhou YF; Feng L; Zhang DL; Liu WH
    Chin Med J (Engl); 2009 Dec; 122(24):2977-80. PubMed ID: 20137485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
    Davies SJ; Bryan J; Phillips L; Russell GI
    Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.
    Szeto CC; Law MC; Wong TY; Leung CB; Li PK
    Am J Kidney Dis; 2001 Feb; 37(2):329-36. PubMed ID: 11157374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.